JP Morgan Chase’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.3K Buy
3,289
+89
+3% +$1.48K ﹤0.01% 6223
2025
Q4
$57.7K Buy
3,200
+369
+13% +$6.35K ﹤0.01% 6168
2025
Q3
$45.6K Buy
2,831
+1,012
+56% +$14.8K ﹤0.01% 6264
2025
Q2
$19.8K Sell
1,819
-365
-17% -$4.09K ﹤0.01% 6176
2025
Q1
$27.3K Sell
2,184
-364
-14% -$6K ﹤0.01% 6060
2024
Q4
$50.5K Buy
+2,548
New +$28.2K ﹤0.01% 6010
2020
Q4
Sell
-50,000
Closed -$1.92M 5813
2020
Q3
$1.92M Buy
+50,000
New +$1.57M ﹤0.01% 3262
2020
Q2
Sell
-738
Closed -$6K 5570
2020
Q1
$6K Buy
+738
New +$11.3K ﹤0.01% 5104
2019
Q4
Sell
-9,285
Closed -$128K 5770
2019
Q3
$128K Buy
+9,285
New +$102K ﹤0.01% 4814
2018
Q2
Sell
-3,891
Closed -$45K 5622
2018
Q1
$45K Buy
+3,891
New +$46.8K ﹤0.01% 4852

Other funds holding MESO

JP Morgan Chase's MESO Position: Q1 2026 in Review

JP Morgan Chase increased its Mesoblast (MESO) stake by 2.8% in Q1 2026, buying an estimated $1.48K and bringing the position to 3,289 shares worth $47.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6223.

JP Morgan Chase first reported a position in MESO in Q1 2018 and has held it in 10 quarters since. The position peaked at $1.92M in Q3 2020. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • JP Morgan Chase held 3,289 shares of Mesoblast worth $47.3K as of Q1 2026.
  • JP Morgan Chase bought 89 Mesoblast shares in Q1 2026, an estimated $1.48K.
  • Mesoblast made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6223 holding.
  • JP Morgan Chase first reported a position in Mesoblast in Q1 2018 and has held it in 10 quarters since.
  • JP Morgan Chase's Mesoblast position peaked at $1.92M in Q3 2020.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.